Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.1386-3.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -80.49% | -80.43% | -58.94% | -50.69% | -21.27% |
| Total Depreciation and Amortization | 4.15% | 4.15% | 10.88% | 7.88% | 13.53% |
| Total Amortization of Deferred Charges | 17.61% | 17.61% | 58.05% | 22.25% | 64.15% |
| Total Other Non-Cash Items | 831.31% | 229.66% | 180.12% | 161.86% | 110.52% |
| Change in Net Operating Assets | 76.99% | 76.99% | -21.31% | -38.71% | -24.96% |
| Cash from Operations | -9.56% | -5.04% | -13.39% | -32.92% | 13.57% |
| Capital Expenditure | 14.79% | -11.68% | -9.42% | 15.53% | 30.54% |
| Sale of Property, Plant, and Equipment | -62.47% | -57.02% | -89.81% | -89.90% | 175.35% |
| Cash Acquisitions | -4.67% | -4.03% | 91.37% | -281.61% | -73.94% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -995.54% | -345.05% | -291.54% | -200.76% | 71.04% |
| Cash from Investing | -374.65% | -202.07% | -181.70% | -161.08% | 48.34% |
| Total Debt Issued | 14.41% | 5.59% | -10.78% | 3.58% | -0.60% |
| Total Debt Repaid | -65.55% | -51.28% | -0.63% | -4.59% | -34.08% |
| Issuance of Common Stock | 10.41% | -12.70% | -23.39% | -44.95% | -49.07% |
| Repurchase of Common Stock | -422.28% | -422.28% | 38.68% | 38.68% | 90.01% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.55% | -9.50% | -3.79% | -477.96% | -0.79% |
| Other Financing Activities | 35.57% | 15.39% | -502.89% | -1,488.61% | -493.09% |
| Cash from Financing | -511.34% | -9,085.42% | -246.75% | -140.68% | -149.08% |
| Foreign Exchange rate Adjustments | -81.70% | -176.32% | 27.58% | -162.86% | -29.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,092.22% | -1,320.11% | -1,604.57% | -1,318.77% | 71.09% |